Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy.
Koshkin VS, Danchaivijitr P, Bae WK, Semenov A, Ozyilkan O, Su YL, Arranz Arija JA, Tsujihata M, Bögemann M, Hendriks MP, Delgado SN, Rosenbaum E, Lopez KA, Bavle A, Liu CC, Imai K, Furka A.
Koshkin VS, et al. Among authors: bae wk.
Eur Urol. 2024 Dec 20:S0302-2838(24)02706-4. doi: 10.1016/j.eururo.2024.11.012. Online ahead of print.
Eur Urol. 2024.
PMID: 39709248